Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2529
-0.0041 (-1.60%)
At close: Aug 28, 2026, 4:00 PM EDT
0.2602
+0.0073 (2.89%)
After-hours: Aug 28, 2026, 7:57 PM EDT

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $1.48M in the quarter ending June 30, 2026, with 504.92% growth. This brings the company's revenue in the last twelve months to $2.50M, up 287.31% year-over-year. In the fiscal year ending March 31, 2026, Vistagen Therapeutics had annual revenue of $1.27M with 161.11% growth.

Revenue (ttm)
$2.50M
Revenue Growth
+287.31%
P/S Ratio
4.49
Revenue / Employee
$61,000
Employees
41
Market Cap
11.22M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.27M783.00K161.11%
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Daré Bioscience1.37M
CytoMed Therapeutics669.28K
Aspire Biopharma Holdings97.66K
Senti Biosciences Holdings55.00K
Kiora Pharmaceuticals20.00K
Azitra7.50K
Aprea Therapeutics5.19K
Revenue Rankings

VTGN News

More News